Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 57.97 -0.39 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.36 | 52 Week High | $8.22 | |||
| Open | $58.15 | 52 Week Low | $3.07 | |||
| Day High | $58.15 | P/E | N/A | |||
| Day Low | $56.56 | EPS | $-1.30 | |||
| Volume | 257,295 | |||||
